• Am J Health Syst Pharm · Dec 2015

    Comparative Study Observational Study

    Comparison of antibiotic susceptibility of Escherichia coli in urinary isolates from an emergency department with other institutional susceptibility data.

    • Catherine Zatorski, Jeanne A Jordan, Sara E Cosgrove, Mark Zocchi, and Larissa May.
    • Catherine Zatorski, B.A., is Research Coordinator, Departments of Emergency Medicine and Infectious Diseases; and Jeanne A. Jordan, PH.D., is Professor, Department of Epidemiology and Biostatistics, School of Public Health and Health Services, George Washington University, Washington, DC. Sara E. Cosgrove, M.D., M.S., is Director of Antimicrobial Stewardship and Associate Professor, Department of Medicine, Division of Infectious Diseases, Johns Hopkins Medical Institutions, Baltimore, MD. Mark Zocchi, M.P.H., is Senior Research Associate, Office of Clinical Practice Innovation; and Larissa May, M.D., M.S.P.H., M.S.H.S., is Associate Professor and Associate Director of Clinical Research, Department of Emergency Medicine, George Washington University.
    • Am J Health Syst Pharm. 2015 Dec 15; 72 (24): 2176-80.

    PurposeThe antibiotic susceptibility of Escherichia coli in isolates from patients with uncomplicated urinary tract infection (UTI) in an emergency department (ED) was compared with susceptibility data from the associated hospital.MethodsPatients eligible for study participation included women age 18-65 years with one or more symptoms consistent with a UTI for whom a urine dipstick, urinalysis, or urine culture was ordered. Clinical decision-making, including the decision to order a urine culture, was at the discretion of the individual healthcare provider; however, a deidentified urine culture and antimicrobial susceptibility testing were performed for those study participants for whom a urine culture was not ordered. We compared the E. coli-specific antibiogram for uncomplicated UTI to the antibiogram based on all urine cultures in the ED regardless of patient disposition, non-intensive care unit (ICU) hospital inpatients, and the hospitalwide antibiogram.ResultsOf the 578 ED patients screened for study eligibility, 119 met the inclusion criteria. E. coli, detected in 53 (74%) of the 72 pathogen-positive cultures, was the most common pathogen isolated. For E. coli, ciprofloxacin nonsusceptibility was significantly less common in isolates from ED patients with uncomplicated cystitis and pyelonephritis than in isolates from non-ICU inpatients or from the hospitalwide population. E. coli nonsusceptibility to ciprofloxacin was significantly less common in ED isolates from patients with uncomplicated UTI than in isolates from all ED patients with clinician-ordered urine cultures.ConclusionAntibiotic susceptibility of E. coli in an ED and its associated hospital depended on factors such as whether patients were hospitalized and whether ED isolates were from patients with uncomplicated UTI.Copyright © 2015 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.